Khan I - Search Results

1

Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.

Ibrar A, Tehseen Y, Khan I, Hameed A, Saeed A, Furtmann N, Bajorath J, Iqbal J. Ibrar A, et al. Among authors: khan i. Bioorg Chem. 2016 Oct;68:177-86. doi: 10.1016/j.bioorg.2016.08.005. Epub 2016 Aug 6. Bioorg Chem. 2016. PMID: 27544072

2

Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives.

Khan I, Ali S, Hameed S, Rama NH, Hussain MT, Wadood A, Uddin R, Ul-Haq Z, Khan A, Ali S, Choudhary MI. Khan I, et al. Among authors: khan a. Eur J Med Chem. 2010 Nov;45(11):5200-7. doi: 10.1016/j.ejmech.2010.08.034. Epub 2010 Aug 18. Eur J Med Chem. 2010. PMID: 20828889

3

2-(4-Methyl-phen-yl)-2-oxoethyl 3-bromo-benzoate.

Khan I, Ibrar A, Korzański A, Kubicki M. Khan I, et al. Acta Crystallogr Sect E Struct Rep Online. 2012 Dec 1;68(Pt 12):o3465. doi: 10.1107/S1600536812046995. Epub 2012 Nov 28. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 23476275 Free PMC article.

4

Triazolothiadiazoles and triazolothiadiazines--biologically attractive scaffolds.

Khan I, Ibrar A, Abbas N. Khan I, et al. Eur J Med Chem. 2013 May;63:854-68. doi: 10.1016/j.ejmech.2013.01.060. Epub 2013 Mar 5. Eur J Med Chem. 2013. PMID: 23603045 Review.

5

Structurally diversified heterocycles and related privileged scaffolds as potential urease inhibitors: a brief overview.

Ibrar A, Khan I, Abbas N. Ibrar A, et al. Among authors: khan i. Arch Pharm (Weinheim). 2013 Jun;346(6):423-46. doi: 10.1002/ardp.201300041. Epub 2013 May 28. Arch Pharm (Weinheim). 2013. PMID: 23712847 Review.

6

Oxadiazoles as privileged motifs for promising anticancer leads: recent advances and future prospects.

Khan I, Ibrar A, Abbas N. Khan I, et al. Arch Pharm (Weinheim). 2014 Jan;347(1):1-20. doi: 10.1002/ardp.201300231. Epub 2013 Nov 22. Arch Pharm (Weinheim). 2014. PMID: 24265208 Review.

7

Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications.

Khan I, Ibrar A, Abbas N, Saeed A. Khan I, et al. Eur J Med Chem. 2014 Apr 9;76:193-244. doi: 10.1016/j.ejmech.2014.02.005. Epub 2014 Feb 7. Eur J Med Chem. 2014. PMID: 24583357 Review.

8

Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.

Khan I, Zaib S, Ibrar A, Rama NH, Simpson J, Iqbal J. Khan I, et al. Eur J Med Chem. 2014 May 6;78:167-77. doi: 10.1016/j.ejmech.2014.03.046. Epub 2014 Mar 19. Eur J Med Chem. 2014. PMID: 24681981

9

Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.

Khan I, Ibrar A, Zaib S, Ahmad S, Furtmann N, Hameed S, Simpson J, Bajorath J, Iqbal J. Khan I, et al. Bioorg Med Chem. 2014 Nov 1;22(21):6163-73. doi: 10.1016/j.bmc.2014.08.026. Epub 2014 Sep 6. Bioorg Med Chem. 2014. PMID: 25257911

10

Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue.

Khan I, Ibrar A, Ahmed W, Saeed A. Khan I, et al. Eur J Med Chem. 2015 Jan 27;90:124-69. doi: 10.1016/j.ejmech.2014.10.084. Epub 2014 Nov 5. Eur J Med Chem. 2015. PMID: 25461317 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,339 results

Search Page

Filters